
The global market for Next-generation Sequencing Service was valued at US$ 169 million in the year 2024 and is projected to reach a revised size of US$ 462 million by 2031, growing at a CAGR of 15.7% during the forecast period.
North American market for Next-generation Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Next-generation Sequencing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Next-generation Sequencing Service in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Next-generation Sequencing Service include Illumina, Qiagen N.V., PerkinElmer, Eurofins Scientific S.E., Macrogen, LGC Limited, GENEWIZ, Beijing Genomics Institute, SciGenom Labs, MedGenome, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next-generation Sequencing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-generation Sequencing Service.
The Next-generation Sequencing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-generation Sequencing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-generation Sequencing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Qiagen N.V.
PerkinElmer
Eurofins Scientific S.E.
Macrogen
LGC Limited
GENEWIZ
Beijing Genomics Institute
SciGenom Labs
MedGenome
Natera
BGI
Roche
LabCorp
Brooks Life Sciences
Novogene
Segment by Type
DNA
RNA
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-generation Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-generation Sequencing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA
1.2.3 RNA
1.3 Market by Application
1.3.1 Global Next-generation Sequencing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-generation Sequencing Service Market Perspective (2020-2031)
2.2 Global Next-generation Sequencing Service Growth Trends by Region
2.2.1 Global Next-generation Sequencing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Next-generation Sequencing Service Historic Market Size by Region (2020-2025)
2.2.3 Next-generation Sequencing Service Forecasted Market Size by Region (2026-2031)
2.3 Next-generation Sequencing Service Market Dynamics
2.3.1 Next-generation Sequencing Service Industry Trends
2.3.2 Next-generation Sequencing Service Market Drivers
2.3.3 Next-generation Sequencing Service Market Challenges
2.3.4 Next-generation Sequencing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-generation Sequencing Service Players by Revenue
3.1.1 Global Top Next-generation Sequencing Service Players by Revenue (2020-2025)
3.1.2 Global Next-generation Sequencing Service Revenue Market Share by Players (2020-2025)
3.2 Global Next-generation Sequencing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Next-generation Sequencing Service Revenue
3.4 Global Next-generation Sequencing Service Market Concentration Ratio
3.4.1 Global Next-generation Sequencing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-generation Sequencing Service Revenue in 2024
3.5 Global Key Players of Next-generation Sequencing Service Head office and Area Served
3.6 Global Key Players of Next-generation Sequencing Service, Product and Application
3.7 Global Key Players of Next-generation Sequencing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-generation Sequencing Service Breakdown Data by Type
4.1 Global Next-generation Sequencing Service Historic Market Size by Type (2020-2025)
4.2 Global Next-generation Sequencing Service Forecasted Market Size by Type (2026-2031)
5 Next-generation Sequencing Service Breakdown Data by Application
5.1 Global Next-generation Sequencing Service Historic Market Size by Application (2020-2025)
5.2 Global Next-generation Sequencing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Next-generation Sequencing Service Market Size (2020-2031)
6.2 North America Next-generation Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Next-generation Sequencing Service Market Size by Country (2020-2025)
6.4 North America Next-generation Sequencing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-generation Sequencing Service Market Size (2020-2031)
7.2 Europe Next-generation Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Next-generation Sequencing Service Market Size by Country (2020-2025)
7.4 Europe Next-generation Sequencing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-generation Sequencing Service Market Size (2020-2031)
8.2 Asia-Pacific Next-generation Sequencing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Next-generation Sequencing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Next-generation Sequencing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-generation Sequencing Service Market Size (2020-2031)
9.2 Latin America Next-generation Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Next-generation Sequencing Service Market Size by Country (2020-2025)
9.4 Latin America Next-generation Sequencing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-generation Sequencing Service Market Size (2020-2031)
10.2 Middle East & Africa Next-generation Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Next-generation Sequencing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Next-generation Sequencing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next-generation Sequencing Service Introduction
11.1.4 Illumina Revenue in Next-generation Sequencing Service Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Qiagen N.V.
11.2.1 Qiagen N.V. Company Details
11.2.2 Qiagen N.V. Business Overview
11.2.3 Qiagen N.V. Next-generation Sequencing Service Introduction
11.2.4 Qiagen N.V. Revenue in Next-generation Sequencing Service Business (2020-2025)
11.2.5 Qiagen N.V. Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Next-generation Sequencing Service Introduction
11.3.4 PerkinElmer Revenue in Next-generation Sequencing Service Business (2020-2025)
11.3.5 PerkinElmer Recent Development
11.4 Eurofins Scientific S.E.
11.4.1 Eurofins Scientific S.E. Company Details
11.4.2 Eurofins Scientific S.E. Business Overview
11.4.3 Eurofins Scientific S.E. Next-generation Sequencing Service Introduction
11.4.4 Eurofins Scientific S.E. Revenue in Next-generation Sequencing Service Business (2020-2025)
11.4.5 Eurofins Scientific S.E. Recent Development
11.5 Macrogen
11.5.1 Macrogen Company Details
11.5.2 Macrogen Business Overview
11.5.3 Macrogen Next-generation Sequencing Service Introduction
11.5.4 Macrogen Revenue in Next-generation Sequencing Service Business (2020-2025)
11.5.5 Macrogen Recent Development
11.6 LGC Limited
11.6.1 LGC Limited Company Details
11.6.2 LGC Limited Business Overview
11.6.3 LGC Limited Next-generation Sequencing Service Introduction
11.6.4 LGC Limited Revenue in Next-generation Sequencing Service Business (2020-2025)
11.6.5 LGC Limited Recent Development
11.7 GENEWIZ
11.7.1 GENEWIZ Company Details
11.7.2 GENEWIZ Business Overview
11.7.3 GENEWIZ Next-generation Sequencing Service Introduction
11.7.4 GENEWIZ Revenue in Next-generation Sequencing Service Business (2020-2025)
11.7.5 GENEWIZ Recent Development
11.8 Beijing Genomics Institute
11.8.1 Beijing Genomics Institute Company Details
11.8.2 Beijing Genomics Institute Business Overview
11.8.3 Beijing Genomics Institute Next-generation Sequencing Service Introduction
11.8.4 Beijing Genomics Institute Revenue in Next-generation Sequencing Service Business (2020-2025)
11.8.5 Beijing Genomics Institute Recent Development
11.9 SciGenom Labs
11.9.1 SciGenom Labs Company Details
11.9.2 SciGenom Labs Business Overview
11.9.3 SciGenom Labs Next-generation Sequencing Service Introduction
11.9.4 SciGenom Labs Revenue in Next-generation Sequencing Service Business (2020-2025)
11.9.5 SciGenom Labs Recent Development
11.10 MedGenome
11.10.1 MedGenome Company Details
11.10.2 MedGenome Business Overview
11.10.3 MedGenome Next-generation Sequencing Service Introduction
11.10.4 MedGenome Revenue in Next-generation Sequencing Service Business (2020-2025)
11.10.5 MedGenome Recent Development
11.11 Natera
11.11.1 Natera Company Details
11.11.2 Natera Business Overview
11.11.3 Natera Next-generation Sequencing Service Introduction
11.11.4 Natera Revenue in Next-generation Sequencing Service Business (2020-2025)
11.11.5 Natera Recent Development
11.12 BGI
11.12.1 BGI Company Details
11.12.2 BGI Business Overview
11.12.3 BGI Next-generation Sequencing Service Introduction
11.12.4 BGI Revenue in Next-generation Sequencing Service Business (2020-2025)
11.12.5 BGI Recent Development
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Next-generation Sequencing Service Introduction
11.13.4 Roche Revenue in Next-generation Sequencing Service Business (2020-2025)
11.13.5 Roche Recent Development
11.14 LabCorp
11.14.1 LabCorp Company Details
11.14.2 LabCorp Business Overview
11.14.3 LabCorp Next-generation Sequencing Service Introduction
11.14.4 LabCorp Revenue in Next-generation Sequencing Service Business (2020-2025)
11.14.5 LabCorp Recent Development
11.15 Brooks Life Sciences
11.15.1 Brooks Life Sciences Company Details
11.15.2 Brooks Life Sciences Business Overview
11.15.3 Brooks Life Sciences Next-generation Sequencing Service Introduction
11.15.4 Brooks Life Sciences Revenue in Next-generation Sequencing Service Business (2020-2025)
11.15.5 Brooks Life Sciences Recent Development
11.16 Novogene
11.16.1 Novogene Company Details
11.16.2 Novogene Business Overview
11.16.3 Novogene Next-generation Sequencing Service Introduction
11.16.4 Novogene Revenue in Next-generation Sequencing Service Business (2020-2025)
11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Illumina
Qiagen N.V.
PerkinElmer
Eurofins Scientific S.E.
Macrogen
LGC Limited
GENEWIZ
Beijing Genomics Institute
SciGenom Labs
MedGenome
Natera
BGI
Roche
LabCorp
Brooks Life Sciences
Novogene
Ìý
Ìý
*If Applicable.
